These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 23583252)
1. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. Rodés-Cabau J; Dauerman HL; Cohen MG; Mehran R; Small EM; Smyth SS; Costa MA; Mega JL; O'Donoghue ML; Ohman EM; Becker RC J Am Coll Cardiol; 2013 Dec; 62(25):2349-2359. PubMed ID: 23583252 [TBL] [Abstract][Full Text] [Related]
2. Antithrombotic treatment in patients undergoing transcatheter aortic valve implantation (TAVI). Nijenhuis VJ; Bennaghmouch N; van Kuijk JP; Capodanno D; ten Berg JM Thromb Haemost; 2015 Apr; 113(4):674-85. PubMed ID: 25653053 [TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events following transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis. Panchal HB; Ladia V; Desai S; Shah T; Ramu V Am J Cardiol; 2013 Sep; 112(6):850-60. PubMed ID: 23756547 [TBL] [Abstract][Full Text] [Related]
14. A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. Tay EL; Gurvitch R; Wijesinghe N; Nietlispach F; Wood D; Cheung A; Ye J; Lichtenstein SV; Carere R; Thompson C; Webb JG JACC Cardiovasc Interv; 2011 Dec; 4(12):1290-7. PubMed ID: 22192370 [TBL] [Abstract][Full Text] [Related]
15. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients. Piazza N; Kalesan B; van Mieghem N; Head S; Wenaweser P; Carrel TP; Bleiziffer S; de Jaegere PP; Gahl B; Anderson RH; Kappetein AP; Lange R; Serruys PW; Windecker S; Jüni P JACC Cardiovasc Interv; 2013 May; 6(5):443-51. PubMed ID: 23702009 [TBL] [Abstract][Full Text] [Related]
16. Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face? Barbanti M; Gulino S; Tamburino C; Capodanno D Expert Rev Cardiovasc Ther; 2016; 14(3):381-9. PubMed ID: 26601574 [TBL] [Abstract][Full Text] [Related]
17. [Commentary by the German Society for Thoracic and Cardiovascular Surgery on the positions statement by the German Cardiology Society on quality criteria for transcatheter aortic valve implantation (TAVI)]. Cremer J; Heinemann MK; Mohr FW; Diegeler A; Beyersdorf F; Niehaus H; Ensminger S; Schlensak C; Reichenspurner H; Rastan A; Trummer G; Walther T; Lange R; Falk V; Beckmann A; Welz A; ; Thorac Cardiovasc Surg; 2014 Dec; 62(8):639-44. PubMed ID: 25415629 [TBL] [Abstract][Full Text] [Related]